NCT00130338View on ClinicalTrials.gov

Rivastigmine Capsules in Patients With Probable Vascular Dementia

PHASE3CompletedINTERVENTIONAL

Enrollment

521

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Vascular Dementia

Interventions

DRUG

Rivastigmine

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY